FindTrial
Sign In

Serosurvey for antibodies against SARS-CoV-2 in Pune city

Epidemiological and Serological Surveillance of COVID-19 in Pune

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026509
Enrollment
1520
Registered
2020-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Persisten Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults above the age of 18 will be recruited.

Exclusion criteria

Exclusion criteria: COVID positive patients and critically ill will be excluded.

Design outcomes

Primary

MeasureTime frame
Estimate of seroprevalence of antibodies against SARS-CoV-2.Timepoint: 6 months—

Secondary

MeasureTime frame
Identifying risk factors and role of exposure.Timepoint: 6 months—

Countries

India

Contacts

Public ContactL S Shashidhara

Indian Institute of Science Education and Research Pune

aurnab@iiserpune.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026